Author Archives: Hackney Publications
Latest Issue of Sports Medicine and the Law Hits the Stands, Tackling Key Issues Involving the Legal Side of Sports Medicine
Hackney Publications, the nation’s leading publisher of sports law periodicals, has announced that the Fall issue of Sports Medicine and the Law (SML), a quarterly electronic newsletter, has published. It features key stories about relevant topics involving the legal side of sports medicine.
SML, which is available on a complimentary basis, can be subscribed to at the site – https://sportsmedicinelaws.com/. The publication is sponsored by the nation’s leading firm in this area of law – Montgomery McCracken (https://www.mmwr.com/).
Among the articles in the latest issue are:
- Potential Expansion of Athletic Programs’ Duty of Care and New Limitations to Waivers of Liability
- Insurance Is Not Killing Football, Other Contact Sports — It’s Making Them Safer
- Exercise As Punishment? Drop And Give Me 20 . . . Hundred Thousand Dollars
- The Cover-Up Is Always Worse Than The Concussion
- Sports Medicine and Sports Law Serve as the Foundation of Tulane’s Center of Sport and Its Unique Educational Model
- Court: School District Shielded by Immunity in Concussion Case
- DeMeco Ryans and a Career-Ending Injury: On to Arbitration!
“In less than a year, Sports Medicine and the Law has become the go-to resource for athletic trainers, doctors, attorneys and other risk management-minded professionals,” said Holt Hackney, the publication’s managing editor.
“We’re excited to be able to continue to provide this publication on a complimentary basis as a way to increase awareness about the legal side of the business.”
About Hackney Publications
Hackney Publications is the nation’s leading publisher of sports law periodicals. While some of the publications are supported by subscriptions, others are supported by advertising and sponsorship. The latter represents the most significant area of growth for Hackney Publications. Aside from Sports Medicine and the Law, the company also publishes newsletters with Jackson Lewis (Title IX Alert), Wilson Elser (Concussion Defense Reporter), and Skadden (eSports and the Law).
Concussed Football Player Sues School District After Coach Tells Him to ‘Man Up’ Among Stories in Latest Concussion Litigation Reporter
Concussion Litigation Reporter, November 2019, Vol. 8, No. 5
Timely reporting on developments and legal strategies at the intersection of sports and concussions—articles that benefit practicing attorneys who may be pursuing a claim or defending a client.
Table of Contents
Concussed High School Football Player Sues School District After Coach Allegedly Tells Him to ‘Man Up’ and ‘Get Back Out There’
NFHS Sparks Controversy With Position Paper Claiming No Linkage Between CTE and Playing High School Football
Mets Fan Sues Team After Getting Hit in the Head by a T-shirt Fired from a T-shirt and Suffering Concussion
Doctor and Co-Founder of Tulane’s Center of Sport Talks Concussions
WWE Challenges Lawsuit Brought by Former Wrestlers
Chronic Traumatic Encephalopathy: Basic Issues to Consider in Traumatic Brain Injury Litigation
Study Finds No Link Between Youth Contact Sports and Cognitive, Mental Health Problems
Federal Trade Commission Sues Dallas-Based Maker of Brain Health Supplements, Citing Deceptive Claims
Subscribe by visiting here.
Traumatic brain injuries (TBI), including concussions, can be caused by anything from sports injuries to battlefield trauma. And they can have fatal or lasting effects. The results of a severe concussion–problems with thinking, memory, movement, emotions–are clear. The causes, or underlying pathological mechanisms, were not.
A new study questions the ongoing hypothesis that the blunt force behind a traumatic brain injury causes nerve damage, or axonal injury. A team of researchers, including Cold Spring Harbor Laboratory professor Partha Mitra, found greater signs of blood vessel damage than nerve damage after performing post mortem scans on an injured brain. The findings could influence the treatment of and development of new drugs for TBI.
“Nerve damage following traumatic brain injuries has been a majority point of view, and therapy as well as drug development has been targeted towards that,” Mitra said. “The idea is that if the mechanism is actually different, therapeutic intervention may also be different.”
Mitra’s lab worked on the research with colleagues at the National Institutes of Health, National Institute of Neurological Disease and Stroke, University of Maryland, Center for Neuroscience and Regenerative Medicine, and Uniformed Services University of the Health Sciences who had been studying human brains of deceased patients using MRI. The CSHL team performed closer analysis on the postmortem brain tissue using a high-throughput neurohistological pipeline (an assemblage of techniques for labeling and visualizing brain slices) Mitra developed to study the wiring of mouse brains.
With MRI, the resolution is limited to several hundred microns, which makes it hard to discern whether nerve fiber (axonal) or blood vessel (vascular) injuries had occurred, Mitra said. Digitally analyzing the postmortem tissue at micron resolution, correlated with the MRI scan, allowed the team to see the vascular injury more clearly.
Mitra focused on areas surrounding lesions, or where the trauma left a physical imprint on the brain. They appeared on MRI scans as “black blobs.” The team used an iron stain (which shows up in blue) for presence of blood and a myelin stain for presence of nerve fiber fragments on the brain samples. They saw a significant amount of iron-marked blood cells across the area where the lesion was located in the brain sample, indicating traumatic microbleeds caused by ruptures along the blood vessels across the brain. The researchers did not observe any significant nerve damage from the myelin stains.
While the researchers could not completely rule out that patients with TMBs also suffered axonal injury, they concluded that traumatic vascular injury is a distinct characteristic of traumatic microbleeds and could be a target for new therapies.
The team also found that traumatic microbleeds often predict future health problems and disabilities for people with TBI, but could not determine the direction of the relationship between TMBs and acute injuries. TMBs could simply be a signature of more severe injury, or they could cause a worse outcome.
Because of this, the team thinks that follow-up experiments are needed to identify the underlying causes and effects of TBI for better diagnosis, prognosis, identifying therapeutic targets and improving patient outcomes.